apoA-V Inhibitors

The chemical class known as apoA-V Inhibitors encompasses a variety of compounds that can indirectly suppress the activity or expression of apoA-V, primarily through their effects on lipid metabolism and triglyceride regulation. Compounds like sulfonylureas and glucocorticoids can influence the metabolic pathways involved in lipid metabolism, potentially leading to changes in apoA-V activity. Beta-blockers and thiazide diuretics, while primarily used for other indications, can also impact lipid profiles, thus potentially affecting apoA-V.

Androgens and synthetic retinoids, through their influence on lipid metabolism, may also indirectly suppress apoA-V. Compounds that mimic the effects of a high carbohydrate diet, such as acarbose, along with chronic alcohol consumption, can disrupt lipid metabolism, thereby potentially influencing apoA-V activity. Cannabinoid receptor agonists and certain nicotinic acid derivatives can have varying effects on lipid profiles, which might affect apoA-V. Progestogens and some antipsychotics, known to impact lipid metabolism, could also have an indirect suppressive effect on apoA-V.